Suppression of neuronal network excitability and seizure-like events by 2-methyl-4-oxo-3H-quinazoline-3-acetyl piperidine in juvenile rat hippocampus: Involvement of a metabotropic glutamate receptor

Neurochemistry International

Volumn 49, Issue 1, 2006, Pages 41-54

  Lasztóczi, Bálint ^a   Emri, Zsuzsa ^a   Szárics, Éva ^a   Héja, László ^a   Simon, Ágnes ^a   Nyikos, Lajos ^a   Kardos, Julianna ^a  

^a CHEMICAL RESEARCH CENTER   (Hungary)

Author keywords

2 Methyl 4 oxo 3H quinazoline 3 acetyl piperidine; Cytosolic Ca2+ ion transients; Glutamate binding targets; Metabotropic glutamate receptors; Network excitability; Seizure like events

Indexed keywords

2 METHYL 4 OXO 3H QUINAZOLIN 3 ACETYLPIPERIDINE; AMPA RECEPTOR ANTAGONIST; GLUTAMATE RECEPTOR; GUANOSINE TRIPHOSPHATE; METABOTROPIC RECEPTOR; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CALCIUM CELL LEVEL; DRUG MECHANISM; HIPPOCAMPUS; ION TRANSPORT; MALE; NERVE CELL NETWORK; NONHUMAN; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR BINDING; SEIZURE; VOLTAGE CLAMP;

AGE FACTORS; ANIMALS; ANTICONVULSANTS; BINDING SITES; CALCIUM CHANNELS; CELL MEMBRANE; EPILEPSY; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; GUANOSINE TRIPHOSPHATE; HIPPOCAMPUS; MALE; NERVE NET; NEURAL INHIBITION; ORGAN CULTURE TECHNIQUES; PATCH-CLAMP TECHNIQUES; PIPERIDINES; PROTEIN SUBUNITS; PYRAMIDAL CELLS; QUINAZOLINES; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; SYNAPTIC TRANSMISSION;

EID: 33646353703     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2005.12.017     Document Type: Article

References (56)

1. Anderson W.W., Lewis D.W., Swartzwelder H.S., and Wilson W.A. Magnesium-free medium activates seizure-like events in the rat hippocampal slice. Brain Res. 398 (1986) 215-219
2. Ango F., Prezeau L., Muller T., Tu J.C., Xiao B., Worley P.F., Pin J.P., Bockaert J., and Fagni L. Agonist-independent activation of metabotropic glutamate receptor by the intracellular protein Homer. Nature 411 (2001) 962-965
3. Anwyl R. Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res. Brain Res. Rev. 29 (1999) 83-120
4. Avoli M. GABA-mediated synchronous potentials and seizure generation. Epilepsia 37 (1996) 1035-1042
5. Bandrowski A.E., Huguenard J.R., and Prince D.A. Baseline glutamate levels affect group I and group II mGluRs in layer V pyramidal neurons of rat sensorimotor cortex. J. Neurophysiol. 89 (2003) 1308-1316
6. Buhl E.H., Otis T.S., and Mody I. Zinc-induced collapse of augmented inhibition by GABA in a temporal lobe epilepsy model. Science 271 (1996) 369-373
7. Chung D.S., Traynelis S.F., Murphy T.J., and Conn J. 4-Methylhomoibotenic acid activates a novel metabotropic glutamate receptor coupled to phosphoinositide hydrolysis. J. Pharmacol. Exp. Ther. 283 (1997) 742-749
8. Congar P., Leinekugel X., Ben-Ari Y., and Crépel V. A Long-lasting calcium-activated nonselective cationic current is generated by synaptic stimulation or exogenous activation of group I metabotropic glutamate receptors in CA1 pyramidal neurons. J. Neurosci. 17 (1997) 5366-5379
9. Contractor A., Swanson G.T., Sailer A., O'Gorman S., and Heinemann S.F. Identification of the kainate receptor subunits underlying modulation of excitatory synaptic transmission in the CA3 region of the hippocampus. J. Neurosci. 15 (2000) 8269-8278
10. Defagot M.C., Villar M.J., and Antonelli M.C. Differential localization of metabotropic glutamate receptors during postnatal development. Dev. Neurosci. 24 (2002) 272-282
11. Demarque M., Villeneuve N., Manent J.-B., Becq H., Represa A., Ben-Ari Y., and Aniksztejn L. Glutamate transporters prevent the generation of seizures in the developing rat neocortex. J. Neurosci. 24 (2004) 3289-3294
12. Dingledine R., Borges K., Bowie D., and Traynelis S.F. The glutamate receptor ion channel. Pharmacol. Rev. 51 (1999) 7-61
13. Doherty J., and Dingledine R. The roles of metabotropic glutamate receptors in seizures and epilepsy. Current Drug Targets. CNS Neurol. Disord. 1 (2002) 251-260
14. Fabian-Fine R., Volknandt W., Fine A., and Stewart M.G. Age-dependent pre- and postsynaptic distribution of AMPA receptors at synapses in CA3 stratum radiatum of hippocampal slice cultures compared with intact brain. Eur. J. Neurosci. 12 (2000) 3687-3700
15. 2+ induced epileptiform activity in rat hippocampal and enthorhinal cortex slices during adolescence. Dev. Brain Res. 87 (1995) 145-152
16. 3H]L-689,560, an antagonist for the glycine site ont he N-methyl-d-aspartate receptor, to rat brain membranes. Mol. Pharmacol. 41 (1992) 923-930
17. Héja L., Kovács I., Szárics E., Incze M., Temesváriné-Major E., Dörnyei G., Peredy-Kajtár M., Gács-Baitz E., Szántay C., and Kardos J. Novel secoergoline derivatives inhibit both GABA and glutamate uptake in rat brain homogenates: synthesis, in vitro pharmacology, and modeling. J. Med. Chem. 47 (2004) 5620-5629
18. Hsia A.Y., Malenka R.C., and Nicoll R.A. Development of excitatory circuitry in the hippocampus. J. Neurophysiol. 79 (1998) 2013-2024
19. Jensen M.S., and Yaari Y. Role of intrinsic burst firing, potassium accumulation, and electrical coupling in the elevated potassium model of hippocampal epilepsy. J. Neurophysiol. 77 (1997) 1224-1233
20. + transient. J. Neurosci. 15 (1997) 7662-7672
21. Kanumilli S., Toms N.J., and Roberts P.J. Novel metabotropic glutamate receptor negatively coupled to adenylyl cyclase in cultured rat cerebellar astrocytes. Glia 46 (2004) 1-7
22. Kardos J., Kovács I., Blandl T., and Cash D.J. Modulation of GABA flux across rat brain membranes resolved by a rapid quenched incubation technique. Neurosci. Lett. 182 (1994) 73-76
23. Kenakin T. Efficacy as a vector: the relative prevalence and paucity of inverse agonism. Mol. Pharmacol. 65 (2004) 2-11
24. Khazipov R., Khalilov I., Tyzio E., Morozova E., Ben-Ari Y., and Holmes G. Developmental changes in GABAergic actions and seizure susceptibility in the rat hippocampus. Eur. J. Neurosci. 19 (2004) 590-600
25. Klein J., Iovino M., Vakil M., Shinozaki H., and Löffelholz K. Ontogenic and pharmacological studies on metabotropic glutamate receptors coupled to phospholipase D activation. Neuropharmacology 36 (1997) 305-311
26. Kovács I., Lasztóczi B., Szárics E., Héja L., Sági Gy., and Kardos J. Characterisation of an uridine-specific binding site in rat cerebrocortical homogenates. Neurochem. Int. 43 (2003) 101-112
27. Kunishima N., Shimada Y., Tsuji Y., Sato T., Yamamoto M., Kumasaka T., Nakanishi S., Jingami H., and Morikawa K. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407 (2000) 971-977
28. Lasztóczi B., Kovács R., Nyikos L., and Kardos J. A glutamate receptor subtype antagonist inhibits seizures in rat hippocampal slices. Neuroreport 13 (2002) 351-356
29. 2+] model of epilepsy. Eur. J. Neurosci. 19 (2004) 1361-1372
30. Lasztóczi B., Emri Z., Szárics E., Kovács I., and Kardos J. Regulation of network activity in hippocampus by metabotropic glutamate receptors: action mechanism of a novel anticonvulsant. J. Neurochem. 94 Suppl. 2 (2005) 57-57
31. Lee A.C., Wong R.K.S., Chuang S.-C., Shin H.-S., and Bianchi R. Role of synaptic metabotropic glutamate receptors in epileptiform discharges in hippocampal slices. J. Neurophysiol. 88 (2002) 1625-1633
32. Losonczy A., Somogyi P., and Nusser Z. Reduction of excitatory postsynaptic responses by persistently active metabotropic glutamate receptors in the hippocampus. J. Neurophysiol. 89 (2003) 1910-1919
33. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
34. Löscher W. Current status and future directions in the pharmacotherapy of epilepsy. Trends Pharmacol. Sci. 23 (2002) 113-118
35. Luján R., Nusser Z., Roberts J.D., Shigemoto R., and Somogyi P. Perisynaptic location of metabotropic glutamate receptors mGluR1a and mGluR5 on dentrites and dendritic spines in the rat hippocampus. Eur. J. Neurosci. 8 (1996) 1488-1500
36. McBain C.J., and Dingledine R. Dual-component miniature excitatory synaptic currents in rat hippocampal CA3 pyramidal neurons. J. Neurophysiol. 68 (1992) 16-26
37. McCormick D.A., and Contreras D. On the cellular and network bases of epileptic seizures. Annu. Rev. Physiol. 63 (2001) 815-846
38. Meldrum B.S., Akbar M.T., and Chapman A.G. Glutamate receptors and transporters in genetic and acquired models of epilepsy. Epilepsy Res. 36 (1999) 189-204
39. Min M.-Y., Melyan Z., and Kullmann D.M. Synaptically released glutamate reduces γ-aminobutyric acid (GABA)ergic inhibition in the hippocampus via kainate receptors. Proc. Natl. Acad. Sci. USA 96 (1999) 9932-9937
40. Misra S., Satsangi R.K., and Tiwari S.S. Synthesis and CNS activities of some 2-alkyl-3-(2-substituted indol-3-yl)-methyl, 6-substituted-quinazolin-4(3H)-ones. Polish J. Pharmacol. Phar. 34 (1982) 441-447
41. Moldrich R.X., Chapman A.G., De Sarro G., and Meldrum B.S. Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Eur. J. Pharmacol. 476 (2003) 3-16
42. Mori M., and Gerber U. Slow feedback inhibition in the CA3 area of the rat hippocampus by synergistic synaptic activation of mGluR1 and mGluR5. J. Physiol. 544 (2002) 793-799
43. 3H]CPPG. Neuropharmacology 40 (2001) 170-177
44. Otis T.S., Brasnjo G., Dzubay J.A., and Pratap M. Interactions between glutamate transporters and metabotropic glutamate receptors at excitatory synapses in the cerebellar cortex. Neurochem. Int. 45 (2004) 537-544
45. Perez-Velazquez J.L. Bicarbonate-dependent depolarizing potentials in pyramidal cells and interneurons during epileptiform activity. Eur. J. Neurosci. 18 (2003) 1337-1342
46. Pin J.-P., and Acher F. The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. Current Drug Targets. CNS Neurol. Disord. 1 (2002) 297-317
47. Rico M.J., and Merlin L.R. Evidence that phospholipase D activation prevents group I mGluR-induced persistent prolongation of epileptiform bursts. J. Neurophysiol. 91 (2004) 2385-2388
48. Schoepp D.D., Jane D.E., and Monn J.A. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38 (1999) 1431-1476
49. Shigemoto R., Kinoshita A., Wada E., Nomura S., Ohishi H., Takada M., Flor P.J., Neki A., Abe T., Nakanishi S., and Mizuno N. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J. Neurosci. 17 (1997) 7503-7522
50. Semyanov A., and Kullmann D.M. Modulation of GABAergic signaling among interneurons by metabotropic glutamate receptors. Neuron 25 (2000) 663-672
51. Skov J., Nedergaard S., and Andreasen M. New type of synaptically mediated epileptiform activity independent of known glutamate- and GABA-receptors. J. Neurophysiol. 93 (2005) 1845-1856
52. 2+ ion flux to (+)-(S)-alpha-amino-3-hydroxy-5-methylisoxasole-4-propionic acid. Mol. Pharmacol. 59 (2001) 920-928
53. 2+ in the rat hippocampal slice. J. Physiol. 478 (1994) 379-393
54. 3+. Proc. Natl. Acad. Sci. USA 99 (2002) 2660-2665
55. Vizi E.S., Mike A., and Tarnawa I. 2,3-Benzodiazepines (GYKI 52466 and analogs): negative allosteric modulators of AMPA receptors. CNS Drug Rev. 2 (1996) 91-126
56. Zhang C.L., Gloveli T., and Heinemann U. Effects of NMDA and AMPA receptor antagonists on different forms of epileptiform activity in rat temporal cortex slices. Epilepsia 35 (1994) S68-S73